Skip to main content
. 2021 May 5;5(8):1400–1411. doi: 10.1002/hep4.1728

TABLE 1.

Patient Characteristics

Characteristic Total Cohort (n = 31)
Age (years), mean ± SD 62 ± 11
Male sex (%) 58
BMI (kg/m2), mean (n = 30) 26.3
Preoperative liver tests, median [IQR]
Bilirubin (µmol/L) (n = 29) 13 [11‐15]
AST (IU/L) (n = 29) 23 [16‐31]
ALT (IU/L) (n = 29) 26 [19‐35]
GGT (IU/L) (n = 29) 44 [36‐76]
ALP (IU/L) (n = 28) 100 [76‐127]
Liver resection type*
Minor hepatectomy (n = 16)
Posterior sectionectomy (n = 3)
segment resection (n = 7)
Multiple segments resection (<3) (n = 3)
Metastasectomy (n = 3)
Major hepatectomy (n = 15)
Right hemihepatectomy (n = 11)
Left hemihepatectomy (n = 1)
Multiple segments (≥3) (n = 3)
Liver pathology
Metastases (adenocarcinoma), n 28
Nonmalignant liver parenchyma or no sign of metastases, n 3
*

Minor hepatectomy: fewer than three segments; major hepatectomy: three or more segments.

Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; and GGT, gamma glutamyl transferase.